Trillium Asset Management LLC boosted its position in INC Research Holdings, Inc. (NASDAQ:INCR) by 6.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,996 shares of the company’s stock after buying an additional 1,335 shares during the period. Trillium Asset Management LLC’s holdings in INC Research Holdings were worth $1,287,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. increased its position in shares of INC Research Holdings by 40,517.6% in the first quarter. BlackRock Inc. now owns 3,544,294 shares of the company’s stock worth $162,506,000 after buying an additional 3,535,568 shares in the last quarter. MARSHALL WACE ASIA Ltd purchased a new position in shares of INC Research Holdings during the first quarter worth about $37,634,000. Marshall Wace North America L.P. purchased a new position in shares of INC Research Holdings during the first quarter worth about $37,634,000. Redmile Group LLC purchased a new position in shares of INC Research Holdings during the first quarter worth about $29,059,000. Finally, Mackenzie Financial Corp increased its position in shares of INC Research Holdings by 93.1% in the first quarter. Mackenzie Financial Corp now owns 1,196,849 shares of the company’s stock worth $54,876,000 after buying an additional 577,034 shares in the last quarter. Institutional investors own 99.84% of the company’s stock.

Shares of INC Research Holdings, Inc. (NASDAQ INCR) opened at 55.45 on Wednesday. INC Research Holdings, Inc. has a 12 month low of $40.65 and a 12 month high of $61.10. The stock’s 50 day moving average is $56.66 and its 200 day moving average is $52.00. The stock has a market cap of $3.00 billion, a P/E ratio of 33.98 and a beta of 1.42.

INC Research Holdings (NASDAQ:INCR) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.64 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.64. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The business had revenue of $258.10 million during the quarter, compared to the consensus estimate of $256.76 million. During the same quarter last year, the company earned $0.61 earnings per share. The business’s quarterly revenue was down .3% compared to the same quarter last year. Analysts predict that INC Research Holdings, Inc. will post $2.60 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.watchlistnews.com/trillium-asset-management-llc-purchases-1335-shares-of-inc-research-holdings-inc-incr/1494465.html.

INCR has been the subject of a number of recent research reports. TheStreet downgraded shares of INC Research Holdings from a “b” rating to a “c” rating in a research note on Friday, July 28th. Wells Fargo & Company downgraded shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 3rd. Jefferies Group LLC reiterated a “buy” rating and issued a $51.00 price target on shares of INC Research Holdings in a research note on Friday, April 21st. Zacks Investment Research downgraded shares of INC Research Holdings from a “hold” rating to a “sell” rating in a research note on Tuesday, May 16th. Finally, Robert W. Baird upgraded shares of INC Research Holdings from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $46.00 to $66.00 in a research note on Thursday, May 11th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company’s stock. INC Research Holdings presently has an average rating of “Hold” and a consensus target price of $63.79.

In other news, CAO Christopher L. Gaenzle sold 6,873 shares of the firm’s stock in a transaction that occurred on Friday, June 30th. The shares were sold at an average price of $58.32, for a total transaction of $400,833.36. Following the completion of the sale, the chief accounting officer now owns 47,450 shares of the company’s stock, valued at $2,767,284. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Alistair Macdonald sold 10,555 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $58.38, for a total transaction of $616,200.90. Following the sale, the chief executive officer now directly owns 83,935 shares of the company’s stock, valued at approximately $4,900,125.30. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by company insiders.

About INC Research Holdings

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings, Inc. (NASDAQ:INCR).

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.